Download PDF
Semin Thromb Hemost 2018; 44(02): 142-150
DOI: 10.1055/s-0037-1606181
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Tissue Factor Pathway and Wound Healing

Maureane Hoffman
1   Department of Pathology, Duke University and Pathology and Laboratory Medicine Service, Durham VA Medical Center, Durham, North Carolina
› Author Affiliations
Further Information

Publication History

Publication Date:
13 September 2017 (online)

    Permissions and Reprints

Abstract

The role of tissue factor (TF) as the major initiator of hemostatic blood coagulation is well recognized. The ability to form an adequate hemostatic clot is essential to the normal healing of an injury by staunching bleeding, stabilizing the injured tissue, and serving as a scaffold for repair processes. Also, some molecules produced during hemostasis, particularly thrombin, have cytokine and growth factor-like activities that contribute to inflammation and repair. However, TF itself has activities as a regulator of cellular processes via direct signaling, as well as by facilitating activation of proteolytically activated receptors by activated factors VII and X. The importance of hemostasis in the host response to injury makes it very difficult to separate the hemostatic from nonhemostatic effects of TF on wound healing. The literature in this area remains sparse but suggests that TF influences the course and tempo of healing by cell signaling events that impact inflammation, epithelialization, and angiogenesis.

Keywords

hemostasis - tissue factor - tissue repair
 

  • References

  • 1 Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry 1966; 5 (02) 601-608
    CrossrefPubMedGoogle Scholar
  • 2 Nemerson Y, Spaet TH. The activation of factor X by extracts of rabbit brain. Blood 1964; 23: 657-668
    PubMedGoogle Scholar
  • 3 Hvatum M, Prydz H. Studies on tissue thromboplastin--its splitting into two separable parts. Thromb Diath Haemorrh 1969; 21 (02) 217-222
    PubMedGoogle Scholar
  • 4 Mackman N, Morrissey JH, Fowler B, Edgington TS. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989; 28 (04) 1755-1762
    CrossrefPubMedGoogle Scholar
  • 5 Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A 1990; 87 (18) 6934-6938
    CrossrefPubMedGoogle Scholar
  • 6 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134 (05) 1087-1097
    PubMedGoogle Scholar
  • 7 Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59 (02) 421-437
    CrossrefPubMedGoogle Scholar
  • 8 Poulsen LK, Jacobsen N, Sørensen BB. , et al. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273 (11) 6228-6232
    CrossrefPubMedGoogle Scholar
  • 9 Røttingen J-A, Enden T, Camerer E, Iversen J-G, Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 1995; 270 (09) 4650-4660
    CrossrefPubMedGoogle Scholar
  • 10 Pendurthi UR, Alok D, Rao LV. Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc Natl Acad Sci U S A 1997; 94 (23) 12598-12603
    CrossrefPubMedGoogle Scholar
  • 11 Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 2000; 275 (09) 6580-6585
    CrossrefPubMedGoogle Scholar
  • 12 Schaffner F, Ruf W. Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 2009; 29 (12) 1999-2004
    CrossrefPubMedGoogle Scholar
  • 13 Ruf W. Tissue factor and PAR signaling in tumor progression. Thromb Res 2007; 120 (Suppl. 02) S7-S12
    CrossrefPubMedGoogle Scholar
  • 14 Hembrough TA, Swartz GM, Papathanassiu A. , et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 2003; 63 (11) 2997-3000
    PubMedGoogle Scholar
  • 15 Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 1995; 92 (18) 8205-8209
    CrossrefPubMedGoogle Scholar
  • 16 Belting M, Dorrell MI, Sandgren S. , et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10 (05) 502-509
    CrossrefPubMedGoogle Scholar
  • 17 Ott I, Weigand B, Michl R. , et al. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation 2005; 111 (03) 349-355
    CrossrefPubMedGoogle Scholar
  • 18 Sharma L, Melis E, Hickey MJ. , et al. The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol 2004; 165 (01) 331-340
    CrossrefPubMedGoogle Scholar
  • 19 Yang YH, Hall P, Milenkovski G. , et al. Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice. Am J Pathol 2004; 164 (01) 109-117
    CrossrefPubMedGoogle Scholar
  • 20 Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9 (04) 458-462
    CrossrefPubMedGoogle Scholar
  • 21 Kocatürk B, Van den Berg YW, Tieken C. , et al. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013; 110 (28) 11517-11522
    CrossrefPubMedGoogle Scholar
  • 22 Eisenreich A, Boltzen U, Malz R, Schultheiss HP, Rauch U. Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells. Circ J 2011; 75 (05) 1235-1242
    CrossrefPubMedGoogle Scholar
  • 23 van den Berg YW, van den Hengel LG, Myers HR. , et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci U S A 2009; 106 (46) 19497-19502
    CrossrefPubMedGoogle Scholar
  • 24 Hoffman M, Harger A, Lenkowski A, Hedner U, Roberts HR, Monroe DM. Cutaneous wound healing is impaired in hemophilia B. Blood 2006; 108 (09) 3053-3060
    CrossrefPubMedGoogle Scholar
  • 25 McDonald AG, Yang K, Roberts HR, Monroe DM, Hoffman M. Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia. Blood 2008; 111 (04) 2046-2048
    CrossrefPubMedGoogle Scholar
  • 26 Hoffman M, Colina CM, McDonald AG, Arepally GM, Pedersen L, Monroe DM. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost 2007; 5 (07) 1403-1408
    CrossrefPubMedGoogle Scholar
  • 27 Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood 2001; 97 (12) 3691-3698
    CrossrefPubMedGoogle Scholar
  • 28 Stecher VJ. The chemotaxis of selected cell types to connective tissue degradation products. Ann N Y Acad Sci 1975; 256: 177-189
    CrossrefPubMedGoogle Scholar
  • 29 Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol 1976; 32 (04) 507-513
    CrossrefPubMedGoogle Scholar
  • 30 Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986; 77 (03) 1014-1019
    CrossrefPubMedGoogle Scholar
  • 31 Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost 2006; 4 (05) 932-939
    CrossrefPubMedGoogle Scholar
  • 32 Hadjipanayi E, Kuhn PH, Moog P. , et al. The fibrin matrix regulates angiogenic responses within the hemostatic microenvironment through biochemical control. PLoS One 2015; 10 (08) e0135618
    CrossrefPubMedGoogle Scholar
  • 33 Cox S, Cole M, Tawil B. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng 2004; 10 (5-6): 942-954
    CrossrefPubMedGoogle Scholar
  • 34 Inbal A, Lubetsky A, Krapp T. , et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005; 94 (02) 432-437
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 179-186
    PubMedGoogle Scholar
  • 36 Bar-Shavit R, Kahn A, Fenton II JW, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983; 96 (01) 282-285
    CrossrefPubMedGoogle Scholar
  • 37 Pilcher BK, Kim DW, Carney DH, Tomasek JJ. Thrombin stimulates fibroblast-mediated collagen lattice contraction by its proteolytically activated receptor. Exp Cell Res 1994; 211 (02) 368-373
    CrossrefPubMedGoogle Scholar
  • 38 Norfleet AM, Bergmann JS, Carney DH. Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells. Gen Pharmacol 2000; 35 (05) 249-254
    CrossrefPubMedGoogle Scholar
  • 39 Stiernberg J, Norfleet AM, Redin WR, Warner WS, Fritz RR, Carney DH. Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508. Wound Repair Regen 2000; 8 (03) 204-215
    CrossrefPubMedGoogle Scholar
  • 40 Carney DH, Mann R, Redin WR. , et al. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 1992; 89 (05) 1469-1477
    CrossrefPubMedGoogle Scholar
  • 41 Strukova SM, Dugina TN, Chistov IV. , et al. Immobilized thrombin receptor agonist peptide accelerates wound healing in mice. Clin Appl Thromb Hemost 2001; 7 (04) 325-329
    CrossrefPubMedGoogle Scholar
  • 42 Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64 (06) 1057-1068
    CrossrefPubMedGoogle Scholar
  • 43 Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001; 413 (6851): 74-78
    CrossrefPubMedGoogle Scholar
  • 44 Connolly AJ, Suh DY, Hunt TK, Coughlin SR. Mice lacking the thrombin receptor, PAR1, have normal skin wound healing. Am J Pathol 1997; 151 (05) 1199-1204
    PubMedGoogle Scholar
  • 45 Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol 2003; 23 (06) 931-939
    CrossrefPubMedGoogle Scholar
  • 46 Simpson DM, Ross R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest 1972; 51 (08) 2009-2023
    CrossrefPubMedGoogle Scholar
  • 47 McDonald A, Hoffman M, Hedner U, Roberts HR, Monroe DM. Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost 2007; 5 (08) 1577-1583
    CrossrefPubMedGoogle Scholar
  • 48 Martin P, D'Souza D, Martin J. , et al. Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr Biol 2003; 13 (13) 1122-1128
    CrossrefPubMedGoogle Scholar
  • 49 Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol 1999; 38 (05) 380-386
    CrossrefPubMedGoogle Scholar
  • 50 Apostolopoulos J, Hickey MJ, Sharma L. , et al. The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity. J Leukoc Biol 2008; 83 (04) 902-911
    CrossrefPubMedGoogle Scholar
  • 51 Chen J, Kasper M, Heck T. , et al. Tissue factor as a link between wounding and tissue repair. Diabetes 2005; 54 (07) 2143-2154
    CrossrefPubMedGoogle Scholar
  • 52 Hoffman M, Monroe DM. Inflammation does not predispose to bleeding in hemophilia. J Thromb Haemost 2010; 8 (11) 2583-2585
    CrossrefPubMedGoogle Scholar
  • 53 Jaakkola P, Kontusaari S, Kauppi T, Määtä A, Jalkanen M. Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J 1998; 12 (11) 959-969
    CrossrefPubMedGoogle Scholar
  • 54 Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997; 78 (01) 747-754
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140 (05) 1241-1253
    CrossrefPubMedGoogle Scholar
  • 56 Szotowski B, Goldin-Lang P, Antoniak S. , et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005; 45 (07) 1081-1089
    CrossrefPubMedGoogle Scholar
  • 57 Monroe DM, Mackman N, Hoffman M. Wound healing in hemophilia B mice and low tissue factor mice. Thromb Res 2010; 125 (Suppl. 01) S74-S77
    CrossrefPubMedGoogle Scholar
  • 58 Santulli RJ, Derian CK, Darrow AL. , et al. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci U S A 1995; 92 (20) 9151-9155
    CrossrefPubMedGoogle Scholar
  • 59 Hou L, Kapas S, Cruchley AT. , et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 1998; 94 (03) 356-362
    CrossrefPubMedGoogle Scholar
  • 60 Seiberg M, Paine C, Sharlow E. , et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 2000; 254 (01) 25-32
    CrossrefPubMedGoogle Scholar
  • 61 Hachem JP, Houben E, Crumrine D. , et al. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006; 126 (09) 2074-2086
    CrossrefPubMedGoogle Scholar
  • 62 Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270 (21) 12607-12613
    CrossrefPubMedGoogle Scholar
  • 63 Nehls V, Denzer K, Drenckhahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 1992; 270 (03) 469-474
    CrossrefPubMedGoogle Scholar
  • 64 Sommerville L, Gorman K, Crabtree A, Hoffman M. Downregulation of tissue factor in pericytes by a protein kinase C-dependent mechanism. Blood 2015; 126 (23) 4637
    PubMedGoogle Scholar
  • 65 Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2 (02) 209-215
    CrossrefPubMedGoogle Scholar
  • 66 Fernandez PM, Rickles FR. Tissue factor and angiogenesis in cancer. Curr Opin Hematol 2002; 9 (05) 401-406
    CrossrefPubMedGoogle Scholar
  • 67 Döme B, Hendrix MJ, Paku S, Tóvári J, Tímár J. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 2007; 170 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 68 Maniotis AJ, Folberg R, Hess A. , et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155 (03) 739-752
    CrossrefPubMedGoogle Scholar
  • 69 Hoffman M, Monroe DM. Wound healing in haemophilia--breaking the vicious cycle. Haemophilia 2010; 16 (Suppl. 03) 13-18
    PubMedGoogle Scholar